Eureka Institute for Translational Medicine’s Post

𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝘁𝗼 𝗹𝗼𝗼𝗸 𝗼𝘂𝘁 𝗳𝗼𝗿 𝗶𝗻 𝟮𝟬𝟮𝟱 👀 Clinical research in 𝟮𝟬𝟮𝟰 has brought forth transformative treatments, expanding the possibilities of modern medicine.   As we approach 𝟮𝟬𝟮𝟱, several promising therapies are on the horizon. These trials aim to improve treatment outcomes, prevent diseases, and tackle global health challenges. The results can be expected to transform the healthcare landscape in the coming years.   Here are some interesting treatments to look forward to.   Let us know what sparks your enthusiasm the most!  Expecto Health Science Ionis Pharmaceuticals, Inc. Beam Therapeutics University of Oxford Jazz Pharmaceuticals NYU Langone Health University of Nairobi Stanford University

Learn more about completing your PhD in labs like mine!

Highlight new research in an area of clinical pharmaocology and translational science that you are passionate about in your session proposal for #ASCPT2025: https://bit.ly/2JHcTu7

In the atmosphere of scientific researches, #Medical_Research plays a pivotal role in promoting human health, from the discovery of life-saving drugs to the development of preventive strategies. This dynamic field encompasses a wide spectrum of investigations, ranging from the microscopic intricacies of #cellular_function to the macroscopic challenges of #public_health. The collective efforts of researchers worldwide converge to address critical questions, with the ultimate aim of enhancing our understanding of diseases, developing innovative treatments, and improving the overall well-being of individuals and communities. Here, we will provide a short brief of two fields of 10 top medical research trends in 2024: 1- Advanced Biomarker Discovery 2- Collaborative Research Platforms (StartUs Insights)

💥 HOT OFF THE PRESSES: OUR NOVEMBER NEWSLETTER! 💥 A sneak peek of what you'll find: 📍A feature story on #diversity in research 📍Greenspring Media's #MinnesotaMonthly 2024 Top Doctors 📍Behnam Sabayan's lab receives an NIH Award 📍Casey Dorr, PhD, MS, discussed his pharmacogenomics research with the FDA. 📍 See the link in the comments to read more! #newsletter

Showcased a global conference on biomedical innovation, focusing on AI-driven drug development and personalised medicine.Large screens displaying global health statistics and molecular models highlighted the importance of international collaboration and knowledge sharing in the biomedical field. Such conferences provide an exchange platform for biomedical companies, academic institutions and governments to help break through technological barriers and accelerate the diffusion and adoption of medical technologies globally.Through co-operation, all parties are able to effectively integrate resources and jointly address global challenges such as inefficiencies in drug discovery and development and imbalances in healthcare resources. #US#biology#ai#future#technology#newcentury

Seeking Funding for a #TranslationalScience Project? The Small Grants to Advance Translational Science (S-GATS) Program is offering awards of up to $50,000 to support innovative and collaborative projects aimed at advancing the science of translation. The program is designed to address critical challenges in translational research across various diseases and health conditions, while also encouraging the exploration of novel opportunities and pathways. It welcomes projects that target specific translational challenges—such as improving predictions of drug toxicity or efficacy, enhancing data interoperability, or optimizing clinical trial recruitment—as well as those that seek to leverage untapped opportunities within the field. The application process begins with the submission of a competitive Letter of Intent, due by Tuesday, October 8, 2024. If invited, a full proposal will be required by Thursday, December 19, 2024. To ensure that proposed research projects align with the 2025 request for applications, prospective applicants must consult with the S-GATS Program team prior to submitting their Letter of Intent. An information session will be held tomorrow (Thursday, September 12) @ 4PM! For consultation scheduling, registration for the information sessions, or any inquiries, please contact Nadia Prokofieva, MSSc, at sgats@tuftsmedicine.org. Additional information about this funding opportunity can be found on the Tufts CTSI S-GATS Program page. https://lnkd.in/dt4fhKBf Tufts Medical Center Tufts Medicine Tufts University

🟩 We’ve just received a new review article on melanoma for Oncodaily Medical Journal, and it’s now under a peer-review process. 🟢 More articles are on the way. #OncoDailyMedicalJournal is set to change the way in scientific publishing. 💫 Wait for more updates. OncoDaily #ODMJ #article #melanoma #reviewarticle #peerreview #science #publishing #opencall #submissions

Semiofest 2024 is one week away! I am excited to join Luminous thought leaders and accomplished semioticians Malcolm Evans, Natasha Delliston, and Yogi H. to present on "Biosemiotics: Methodologically Evolving Applied Semiotics to Account for More Experiences, Deepen Relationships, and Transform Systems." We will discuss the evolution of applied #semiotics to tackle complex health issues while enhancing R&D, product development and commercial strategy in the #lifesciences. We endorse an evolved model of semiotics, one that builds on the depth of cultural and psychological insight to include biology - from physiology and biochemistry, to clinical treatment and care. We will showcase this through recent #biopharma examples in #obesity and GLP 1s, #raredisease, neurological disease, and more. The application of semiotics has helped the CPG industry innovate, and holds enormous promise for manufacturers of medicines and devices. If you would like a sneak peek, check out our recent panel Society for Applied Anthropology here: https://lnkd.in/dvtr8P3R Semiofest agenda here: https://lnkd.in/ew8tpSa2

A highly recommended course!